KOL Insight

Crohn’s Disease KOL Interview – US, Northeast

This discussion with a US-based key opinion leader (KOL) includes in-depth opinions on many topics in the Crohn’s disease market. In the discussion, the KOL addresses what the future of the Crohn’s disease market will look like. Also discussed are competition in the market, and how certain factors will lead to one agent triumphing over another. Additionally, the discussion covers the significance of black box warnings, as well as the latest approved agent in Crohn’s disease.